Lauder family to sell 11 million shares of Estée Lauder stock

Agilysys CFO Wood has sold shares worth $123,393, a move that may raise questions among investors about the company's financial strategies.

Palo Alto Networks' Executive Vice President, Klarich, has sold $26 million worth of shares. This move has drawn attention as it reflects the company's ongoing financial activities and the executive's personal investment decisions.

Carvana's VP, Palmer, has sold $305,000 worth of shares. This transaction is part of the company's ongoing financial activities and reflects the current market conditions.

Axon Enterprise, the maker of Tasers, has reported disappointing profits that fell short of expectations, leading to a significant drop in its shares. The company is facing challenges due to tariffs, which have impacted its financial performance.

First Busey CAO Phillips has made a notable investment by purchasing shares valued at $34,609, reflecting confidence in the company's future.

Match Group's shares have taken a hit as their Q4 guidance has fallen short of what investors were hoping for. This disappointing outlook has raised concerns about the company's future performance.

Estée Lauder's stock has taken a hit following the announcement of an 11.3 million share offering by the family. This move has raised concerns among investors, leading to a decline in the company's stock price.

Saba Capital has sold its shares in Nuveen Pennsylvania for a total of $344,120. This transaction reflects the firm's ongoing investment strategy and market activities.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.

Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.

Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.

Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.

Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.